Duration of seroprotection of the live attenuated SA-14-14-2 Japanese encephalitis vaccine in children in India

Abstract Background Acute encephalitis syndrome (AES) is a major public health concern in India, and the Japanese Encephalitis (JE) virus is the most common cause of viral encephalitis in Asia affecting children under the age of 15 years. In India, despite the introduction of the JE vaccine (SA-14-1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of travel medicine 2023-04, Vol.30 (2)
Hauptverfasser:	Preethi, L, Alina, M S, Chandran, Lakshmi, Asvin, S, Jagadeesan, M, Vijayakumar, T M, Chitra, V, Pandey, Ashok Kumar, Reddy, Mahendra M, Misra, Brij Ranjan, Kant, Rajni, Bhukya, Prudhvi Lal, Deshpande, Gururaj Rao, Abraham, Priya, Sapkal, Gajanan, Zaman, Kamran
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antibodies, Neutralizing Antibodies, Viral Child Children Cross-Sectional Studies Encephalitis Encephalitis Virus, Japanese Encephalitis, Japanese - prevention & control Enzyme-linked immunosorbent assay Humans IgG antibody Immune response (humoral) Immune status Immunization Immunofluorescence Immunogenicity Immunoglobulin G India Japanese Encephalitis Vaccines Neutralization Public health Vaccines Vaccines, Attenuated Vector-borne diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!